Publications by authors named "S Intidhar Labidi-Galy"

Claim this Profile
E
Editorial: PARP inhibitors resistance: new insights in ovarian cancer therapy.
Oraianthi Fiste, Michalis Liontos, Sana Intidhar Labidi-Galy

Front Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of clinically relevant T cell receptors for personalized T cell therapy using combinatorial algorithms.
Rémy Pétremand, Johanna Chiffelle, Sara Bobisse, Marta A S Perez, Julien Schmidt, S Intidhar Labidi-Galy

Nat Biotechnol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Identification of clinically relevant T cell receptors for personalized T cell therapy using combinatorial algorithms.
Rémy Pétremand, Johanna Chiffelle, Sara Bobisse, Marta A S Perez, Julien Schmidt, S Intidhar Labidi-Galy

Nat Biotechnol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of chemical stability of monoclonal antibody and antibody drug conjugate administered by pressurized intraperitoneal aerosol chemotherapy.
Valentina D'Atri, Guillaume Galy, Mathias Buff, Mateusz Imiołek, Martin Hübner, Sana Intidhar Labidi-Galy

J Pharm Biomed Anal· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Window of opportunity with PD1 blockade before chemoradiotherapy for an advanced stage clear cell carcinoma of the cervix.
Marie-Gabrielle Courtès, Melpomeni Kountouri, Wenwen Wang, Jean-Christophe Tille, Patrick Petignat, S Intidhar Labidi-Galy

Gynecol Oncol Rep· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis